Guidelines for the care of heart transplant recipients
Guidelines for the care of heart transplant recipients
Guidelines for the care of heart transplant recipients
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Costanzo et al.<br />
<strong>Guidelines</strong> <strong>for</strong> Heart Transplant Care<br />
945<br />
ACEI angiotensin converting enzyme inhibitor<br />
ACT activated clotting time<br />
ADA American Diabetes Association<br />
AHA American Heart Association<br />
AMR antibody-mediated rejection<br />
AP aerosolized pentamidine<br />
aPTT activated partial thromboplastin time<br />
ARB angiotensin receptor blocker<br />
ATG anti-thymocyte globulin<br />
AZA azathioprine<br />
BiV biventricular<br />
BMD bone mass density<br />
BNP brain natriuretic peptide<br />
CAV cardiac allograft vasculopathy<br />
CCB calcium channel blocker<br />
CEDIA cloned enzyme donor immunoassay method<br />
CI cardiac index<br />
CKD chronic kidney disease<br />
CO cardiac output<br />
CPB cardiopulmonary bypass<br />
CMV cytomegalovirus<br />
CNI calcineurin inhibitor<br />
CRP C-reactive protein<br />
CS corticosteroid<br />
CT computed tomography<br />
CVP central venous pressure<br />
CYA cyclosporine<br />
CYP3A cytochrome P-450 3A4<br />
DDDR dual-paced, dual-sensed, dual-response to sensing, rate<br />
modulation<br />
DEXA dual energy x-ray absorptiometry<br />
DSA donor specific antibody<br />
ECG electrocardiogram<br />
ED erectile dysfunction<br />
ECMO extracorporeal membrane oxygenation<br />
EMB endomyocardial biopsy<br />
EMIT enzyme multiplied immunoassay technique<br />
ESC European Society <strong>of</strong> Cardiology<br />
EVL everolimus<br />
FFP fresh frozen plasma<br />
GFR glomerular filtration rate<br />
Hgb hemoglobin<br />
HIT heparin-induced thrombocytopenia<br />
HLA human leukocyte antigen<br />
HPLC high-per<strong>for</strong>mance liquid chromatography<br />
HPV human papillomavirus<br />
HRS Heart Rhythm Society<br />
HSV herpes simplex virus<br />
HT <strong>heart</strong> <strong>transplant</strong><br />
ICU intensive <strong>care</strong> unit<br />
Ig immunoglobulin<br />
IgG immunoglobulin G<br />
INR international normalized unit<br />
ISHLT International Society <strong>for</strong> Heart and Lung<br />
Transplantation<br />
IUD intrauterine device<br />
IV intravenous<br />
IVUS intravascular ultrasound<br />
LV left ventricle<br />
LVEF left ventricular ejection fraction<br />
LVH left ventricular hypertrophy<br />
MAOI monoamine oxidase inhibitors<br />
MCS mechanical circulatory support<br />
MDRD equation modified diet in renal disease equation<br />
MMF mycophenolate m<strong>of</strong>etil<br />
MPA mycophenolic acid<br />
mTOR mammalian target <strong>of</strong> rapamycin<br />
MVO 2 mixed venous oxygen<br />
PAWP pulmonary artery wedge pressure<br />
PCC prothrombin plasma concentrates<br />
PFA-100 platelets function assay 100<br />
PGF primary graft failure<br />
PRA panel reactive antibodies<br />
PRES posterior reversible leukoencephalopathy<br />
PSI proliferation signal inhibitor<br />
PTLD post<strong>transplant</strong> lymphoproliferative disorder<br />
PT prothrombin time<br />
PTT partial thromboplastin time<br />
PVR pulmonary vascular resistance<br />
RAP right atrial pressure<br />
rFVII recombinant factor 7<br />
RV right ventricle<br />
sCr serum creatinine<br />
SRL sirolimus<br />
STI sexually transmitted infection<br />
SVT sustained ventricular tachycardia<br />
TAC tacrolimus<br />
TEE transesophageal echocardiogram<br />
TMP/SMZ trimethoprim/sulfamethoxazole<br />
TTE transthoracic echocardiogram<br />
TV tricuspid valve<br />
VAD ventricular assist device<br />
VER ventricular evoked responses<br />
VT ventricular tachycardia<br />
Conflict <strong>of</strong> Interest Disclosures<br />
Contributing Writers and Reviews<br />
Each writing group member and editorial oversight committee<br />
member completed a disclosure <strong>for</strong>m that is maintained<br />
on file at <strong>the</strong> ISHLT headquarters. The conflict <strong>of</strong><br />
interest disclosures are as follows:<br />
Name Commercial Interest Relationship<br />
Allen S. Anderson XDx Grant research/support<br />
David A. Baran XDx Grant research/support<br />
Astellas<br />
Grant research/support<br />
Gilead<br />
Speakers bureau<br />
GSK<br />
Speakers bureau<br />
United Therapeutics<br />
Advisory board<br />
Geetha Bhat<br />
Nothing to disclose
Change language